Ace's $100 million arm can be insured
But risk of long-term deals like Stephen Strasburg's lies solely with the teams
Strasburg is one of just 19 pitchers in the history of baseball to receive a nine-figure contract. That deal — seven years, $175?million — doesn't even begin until next season. And despite the take-a-deep-breath-and-relax pronouncement by the Nationals on Thursday afternoon — an MRI revealed Strasburg's ulnar collateral ligament was intact, that he instead has a “flexor mass strain” in his elbow — next season might still be the next time we see Strasburg pitch.
But as Washington bit its lip and clutched its pocketbook nearly all day Thursday, the worst-case scenario was certainly considered, from inside the offices at Nationals Park to the streets of the city and into the burbs. Among the considerations: If the Nationals committed $175 million to a pitcher beginning in 2017, and that pitcher wasn't able to pitch during most or all of that contract, what would be the financial impact on the franchise?
(This is not to suggest Strasburg won't pitch between 2017 and 2023, the seasons the contract covers. But in that long, slow walk from the mound to the dugout tunnel Wednesday night, it certainly seemed like a second Tommy John elbow ligament reconstruction was among the possibilities, and a second Tommy John surgery comes with no guarantees.)
The quick answer, of course, is that baseball contracts, from a club perspective, are what the terms say they are. In baseball, you don't hear phrases like “guaranteed money,” common parlance in the NFL. In baseball, all the money is guaranteed. If a club cuts a player it signed for $175 million, or that player is hurt and unable to perform, the player is owed not a penny less than $175?million.
Clubs, though, sometimes try to find a way to mitigate risk, the risk they take every time a Strasburg or Max Scherzer or — pick any of the 19 pitchers who have signed those $100 million-plus contracts — takes the mound. The only real recourse: taking out an insurance policy.
Unlike the NBA and NHL, Major League Baseball has no mandatory insurance policy that clubs buy into, insuring the five most expensive contracts on a roster should they miss a certain number of consecutive games. (In the NHL, it's 30.) Baseball clubs must go into an open marketplace and try to purchase insurance on their own.
“The majority of teams do buy insurance,” said Dan Burns, CEO of Pro Financial Services, a company that has been providing such policies for more than 35 years.
The policies, Burns said, are fairly straightforward. The decisions on whether to buy can be difficult. There are four main components that determine the club's cost: the dollar amount of the contract the team wants to insure; whether the player is a pitcher or not, because pitchers cost “probably 21/2 to three times” as much to insure as position players, Burns said; age, because it's cheaper to insure a younger, healthy player; and, finally, the length of the contract, which can get tricky, because companies don't generally issue seven-year policies to cover seven-year contracts, preferring to offer the insurance in two- or three-year chunks.
“It's a pretty volatile space,” Burns said. “These are very large dollar amounts on professional athletes who are at risk of getting hurt.”
The premiums can be expensive, perhaps 3 percent for the contract of a position player, 7 percent for a pitcher. Thus, insuring even the first year of Strasburg's extension, in which he'll make more than $18.3 million, could cost the Nationals close to $1.3 million. In order for a team to collect on an insurance policy, a player must miss a predetermined number of days — usually around 60. And even then, the club would get back only between 60 percent to 80?percent of the player's salary.
“Theoretically, on a contract that size, you would definitely get insurance,” said an executive from another major league club, speaking of Strasburg's deal. “The challenge is that the insurance always asks for exemptions on previous injuries. Anyone will insure anything at a certain cost. But in this case, either they have an exemption for the elbow, which would make the insurance borderline useless, or it's so expensive — $3?[million] to $4 million or something — that a team might be reluctant.”
Burns said previous injuries are a factor, but if a player has returned to the major league level and performed, reservations about health can be overcome.
Still, policies aren't for every club. The Nationals have issued four contracts worth at least $100 million, those to Ryan Zimmerman (six years, $100 million), Jayson Werth (seven years, $126 million), Strasburg and Scherzer (seven years, $210?million). But people with knowledge of their thought process say they have found insuring such deals vexing and expensive. They haven't done it.
Keep in mind, too, that the risk of long-term deals lies solely with the clubs. Strasburg's deal contains player opt-out clauses after 2019 and 2020, so if he's healthy and performing and the market continues to go up (which it will), he could leave the Nationals for a shot at the open market. Should he be hurt or pitching poorly after 2019 or 2020, Washington has no such option.
So, then, risk. Maybe Strasburg returns in a month, ready to go for the playoffs. Even if that's the case, remember when he takes the mound that throwing a baseball isn't a natural motion, that the elbow can break, and that each game, each inning, each pitch brings with it the risk that tens of millions of dollars will be cut from the payroll with a surgeon's knife.